KU ASCO 2019 Update on Recent Developments in AML - CX-01, HuF59 Anti-CD47 Antibody, Ivosidenib + Azacitidine
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Tara Lin
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Tara Lin
Login to view comments.
Click here to Login